Artificial Intelligence technology is being developed and combined with our present technologies to create new unique possibilities for image processing and future innovative products.
Coronavirus (COVID-19) update
The global outbreak of the coronavirus (COVID-19) is putting great stress on both society and business all over the world.
ContextVision places the highest value in the well-being of our employees, clients and partners. We carefully follow guidelines from expert authorities, comply with their recommendations, and take all necessary precautions to minimize our contribution to the spread of the coronavirus.
Company presentation held at shareholder Webinar
Stockholm, February 23rd 2020 – Today ContextVision presented the company at a shareholder webinar...
ContextVision – invitation to company presentation
We are pleased to invite you to a shareholder presentation of Contextvision AB and its 4th quarter a...
ContextVision Webcast Q4 2020
ContextVision's annual sales match with previous record year. ...
-
ContextVision - invitation to company presentation
We are pleased to invite you to a shareholder presentation of Contextvision AB and its 4th quarte...ContextVision’s annual sales match with previous record year
STOCKHOLM – February 18, 2021 – ContextVision, a medical technology software company specializing...ContextVision announces first CE marked digital pathology product
ContextVision today announced that its first digital pathology product in a planned portfolio has...
Latest news
Company presentation held at shareholder Webinar
Stockholm, February 23rd 2020 – Today ContextVision presented the company at a shareholder webinar...
ContextVision – invitation to company presentation
We are pleased to invite you to a shareholder presentation of Contextvision AB and its 4th quarter a...
ContextVision Webcast Q4 2020
ContextVision's annual sales match with previous record year. ...
-
ContextVision - invitation to company presentation
We are pleased to invite you to a shareholder presentation of Contextvision AB and its 4th quarte...ContextVision’s annual sales match with previous record year
STOCKHOLM – February 18, 2021 – ContextVision, a medical technology software company specializing...ContextVision announces first CE marked digital pathology product
ContextVision today announced that its first digital pathology product in a planned portfolio has...
Installed in more than 300K systems worldwide
Already a world leader in image enhancement, ContextVision is now taking its medical analysis know-how into a new field. The near future will see the launch of our first Digital Pathology product, INIFY® Prostate Screening, based on the latest breakthroughs in AI and deep learning.
INVESTOR NEWS
Investor relations
INVESTOR NEWS
Career
ContextVision’s primary strength is our motivated and talented workforce. We want to add to that strength by employing talented individuals who are willing to work for a leading company dedicated to medical imaging and innovative technologies. In return, we will encourage you to develop and manage your career with us, in a stimulating and international environment.
Welcome to ContextVision!
Career
ContextVision’s primary strength is our motivated and talented workforce. We want to add to that strength by employing talented individuals who are willing to work for a leading company dedicated to medical imaging and innovative technologies. In return, we will encourage you to develop and manage your career with us, in a stimulating and international environment.
Welcome to ContextVision!